[Osteosarcoma and brain metastasis]

INTRODUCTION

Since the advent of multimodal therapy, survival among patients with osteosarcoma in general and among those with aggressive tumors has improved. Consequently, the pattern of relapse is also changing. Brain metastasis is considered to be a rare event in osteosarcoma, although recent reports suggest that the incidence of this complication may be increasing.

CASE REPORT

We report two girls with osteoblastic osteosarcoma of the femur with poor response to preoperative chemotherapy. Both patients developed brain metastasis concurrent with or after the development of lung metastasis. Clinical manifestations of brain metastasis were symptoms of intracranial hypertension in one patient, and a complex partial seizure in the other.

DISCUSSION

We advocate periodic neurologic examination and neuroradiologic screening for the early detection of brain involvement in patients whose disease recurs within 1 year of diagnosis, in those with metastasis at diagnosis and in those with a poor histologic response to preoperative chemotherapy.

[Cerebral cavernomas in childhood. clinical presentation and diagnosis]

INTRODUCTION

Intracranial vascular malformations are congenital lesions due to alterations in the development of the arteriolocapillary network. Traditionally they are divided into four types according to their histological characteristics: arteriovenous malformations, cavernous angiomas or cavernomas, venous angiomas and telangectasias. The cavernomas are multilobulated lesions which are clearly delimited and contain blood at different stages of evolution. Histologically they are composed of sinusoidal spaces lined by endothelium and closely interlinked, without intervening nervous tissue. They are usually found at a supratentorial level, and less frequently in the posterior fossa.

PATIENTS AND METHODS

We made a retrospective review of the histories of 11 patients aged between 2 and 10 years, diagnosed as having intracranial cavernomas in which imaging techniques lead to the diagnosis of intracranial cavernoma. In two patients there were multiple cavernomas. We analysed the method of diagnosis and clinical features on presentation.

RESULTS

The clinical features were varied. In six patients the onset of the disorder was with epileptic seizures, three had progressive neurological deficits, one patient had headache and vomiting which progressed to coma and another had a history of non specific fainting and deficit. All but one of the cavernomas were supratentorial.

CONCLUSIONS

Cavernomas are a type of vascular malformation with specific histological features. The usual clinical features are convulsions and parenchymatous bleeding. They are generally supratentorial. The appearance of MR has permitted diagnosis of asymptomatic cavernomas and is currently considered to be the technique of choice for diagnosis.

[Neonatal hypotonia of muscular origin: analysis of 50 cases]

BACKGROUND

Neonatal hypotonia is a common request for neurological consultation. The aim of this study is to describe the main clinical features of muscular hypotonia in newborns at the light of the histopathological findings.

METHODS

We reviewed 50 medical records of hypotonic neonates with abnormal muscular biopsy. In all of the cases, the serum concentration of creatine kinase was determined and biopsies were examined by a qualified neuropathologist.

RESULTS

The most frequent muscular cause of neonatal hypotonia was specific congenital myopathies (23 cases), followed by congenital muscular dystrophy (15 cases), congenital myotonic dystrophy (eight cases) and metabolic myopathies (four cases). The most common specific congenital myopathy was fiber type disproportion (10 cases). The association with joint contractures and the involvement of respiratory muscles were frequent; respiratory complications were the first cause of death.

CONCLUSIONS

Muscular biopsy is required for the definitive diagnosis of specific congenital myopathies, congenital muscular dystrophy and metabolic myopathies. In congenital myotonic dystrophy, the mother is almost always affected; neonates with specific congenital myopathies and congenital muscular dystrophy can be very similar to those with congenital myotonic dystrophy; the examination of the mother, specially a careful search for myotonia, is the best diagnostic clue; if there are signs of myotonia, the diagnosis can be made by molecular genetic study.

[Age for sitting and walking in children born weighing less than 1,500 g and normal motor development at two years of age]

OBJECTIVE

To estimate the corrected age (CA) of acquisition of sitting and walking in very low birth weight infants with normal motor outcome at 2 years of age and to determine whether transient hypertonia is associated with a delay in the acquisition of sitting and walking.

METHODS

Follow-up study of very low birth weight infants (under 1500 g) admitted to the Neonatology Department of the Hospital 12 de Octubre from January 1991 to December 1996. At 2 years of age, 260 infants had normal motor outcome and 36% of these had been diagnosed with transient hypertonia. The age at which sitting and walking were attained was recorded by interview with the parents and was confirmed by examination.

RESULTS

The mean CA at which sitting was attained was 7.2 +/- 1.4 months. Ninety percent of the infants had acquired sitting at a CA of 9 months. Mean age at which walking was attained was 13.4 +/- 2.8 months. Ninety percent could walk at 16 months. Infants with and without transient hypertonia acquired sitting and walking at the same age.

CONCLUSIONS

Ninety percent of very low birth weight infants attained sitting at a CA of 9 months and walking at a CA of 16 months. Transient hypertonia did not modify the pattern of sitting and walking and it could be considered a variation of normality within the development of very premature infants.

[Cerebral palsy and age of sitting and walking in children weighing less than 1,500 g at birth]

OBJECTIVE

To describe the corrected age (CA) of acquisition for sitting and walking in very low birth weight infants with cerebral palsy and to estimate the probability of walking as a function of age of acquisition of sitting and type of cerebral palsy.

METHODS

Follow up study of very low birth weight infants (under 1500 g) admitted to the Neonatology Department of the Hospital 12 de Octubre in Spain between January 1991 and December 1996. At a corrected age of 2 years, 11.5% (34 children) were diagnosed with cerebral palsy. Ages of attainment of sitting and walking were established by interview with the parents and were confirmed by examination. Age of attainment of sitting and type of cerebral palsy were investigated as possible predictors of ambulatory status.

RESULTS

Sitting was attained by 73% of the children. The probability of attainment of sitting at 9 months was 21% and at 18 months it was 68%. Only one child achieved sitting after 18 months. Fifty-three percent of the children became ambulatory. The probability of becoming ambulatory was 24% at 18 months and 47% at 30 months. If sitting was attained before 12 months of age the probability of becoming ambulatory was 47% at 18 months and 76% at 30 months. All children with spastic hemiplegia, 66% of those with diplegia and only 8% of those with quadriplegia became ambulatory.

CONCLUSIONS

Sitting by the age of 12 months was directly related to achieving ambulation. Irrespective of the type of cerebral palsy, all children with hemiplegia and more than 60% of those with diplegia ambulated while children with quadriplegia were much less likely to ambulate.